NCT04221542 2026-03-06Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerAmgenPhase 1 Recruiting479 enrolled
NCT04631601 2025-10-07Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)AmgenPhase 1/2 Terminated65 enrolled